BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17972143)

  • 1. Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers.
    Vidal O; Soriano-Izquierdo A; Pera M; Elizalde JI; Palacín A; Castells A; Piqué JM; Volant A; Metges JP
    J Gastrointest Surg; 2008 Jun; 12(6):1005-14. PubMed ID: 17972143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
    Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
    Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
    Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
    Zhang L; Zhao ZS; Ru GQ; Ma J
    World J Gastroenterol; 2006 Jul; 12(25):3970-6. PubMed ID: 16810742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
    Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
    Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
    Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
    Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer.
    Zhou Y; Li G; Wu J; Zhang Z; Wu Z; Fan P; Hao T; Zhang X; Li M; Zhang F; Li Q; Lu B; Qiao L
    Tumour Biol; 2010 Dec; 31(6):549-58. PubMed ID: 20563765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer.
    Liu YF; Guo S; Zhao R; Chen YG; Wang XQ; Xu KS
    World J Surg; 2012 Jan; 36(1):109-17. PubMed ID: 21773953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.
    Shi H; Xu JM; Hu NZ; Xie HJ
    World J Gastroenterol; 2003 Jul; 9(7):1421-6. PubMed ID: 12854133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
    Heiss MM; Babic R; Allgayer H; Gruetzner KU; Jauch KW; Loehrs U; Schildberg FW
    J Clin Oncol; 1995 Aug; 13(8):2084-93. PubMed ID: 7636552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue.
    Tatsuguchi A; Matsui K; Shinji Y; Gudis K; Tsukui T; Kishida T; Fukuda Y; Sugisaki Y; Tokunaga A; Tajiri T; Sakamoto C
    Hum Pathol; 2004 Apr; 35(4):488-95. PubMed ID: 15116331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
    Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.
    Nekarda H; Schmitt M; Ulm K; Wenninger A; Vogelsang H; Becker K; Roder JD; Fink U; Siewert JR
    Cancer Res; 1994 Jun; 54(11):2900-7. PubMed ID: 8187075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of vascular endothelial growth factor expression in resected gastric cancer.
    Liu L; Ma XL; Xiao ZL; Li M; Cheng SH; Wei YQ
    Asian Pac J Cancer Prev; 2012; 13(7):3089-97. PubMed ID: 22994715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features.
    Feng CW; Wang LD; Jiao LH; Liu B; Zheng S; Xie XJ
    BMC Cancer; 2002 Apr; 2():8. PubMed ID: 11978184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.